SEC Form D · filed June 14, 2021
Ribon Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Cameron M. Wheeler · Cambridge, MADirectorJames M. Audia · Cambridge, MADirectorJonathan M. Root · Cambridge, MADirectorJodie M. Morrison · Cambridge, MADirectorEmma M. Reeve · Cambridge, MADirectorLaura M. Brass · Cambridge, MADirectorMarian M. Nakada · Lexington, MADirectorVictoria M. Richon · Wellesley, MAExec · DirectorCraig Bissell · Tallahassee, FLDirectorColin M. Smith · New Canaan, CTDirectorJason M. Jacobs · Ephrata, PADirectorNatare Capital Management LP · GREENWICH, CTDirectorNatare Capital GP LLC · GREENWICH, CTDirectorTerrence M. Mclean · Jersey City, NJDirectorSvennilson Peter · Lexington, MADirectorEdward M. Stewart · Cambridge, MAExecJason Cavalier · Watertown, MADirectorNancy B. Snyderman, M.D., Facs · Watertown, MADirectorC. A. Merrifield · Watertown, MADirectorW. B. Smith · Watertown, MADirectorJames R. Tobin · Watertown, MADirectorAnthony Taylor · Vancouver, British Columbia, CanadaDirectorMarian M. Nakada · Lexington, MADirectorSvennilson Peter · Lexington, MADirectorEdward M. Stewart · Cambridge, MAExecVictoria M. Richon · Wellesley, MAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗